NOVARTIS N (Germany) Performance
| NOT Stock | 139.50 1.45 1.05% |
On a scale of 0 to 100, NOVARTIS N holds a performance score of 25. The company secures a Beta (Market Risk) of 0.31, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NOVARTIS N's returns are expected to increase less than the market. However, during the bear market, the loss of holding NOVARTIS N is expected to be smaller as well. Please check NOVARTIS N's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether NOVARTIS N's current price movements will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NOVARTIS N are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, NOVARTIS N unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0488 | Last Split Factor 6:5 | Last Split Date 2023-10-04 |
1 | Oak Associates Ltd. OH Raises Stock Position in Novartis AG NVS - MarketBeat | 11/26/2025 |
2 | Novartis to Sell 70.68 percent Stake in Indian Unit - Intellectia AI | 02/19/2026 |
| Begin Period Cash Flow | 11.5 B | |
| Free Cash Flow | 15.2 B |
NOVARTIS |
NOVARTIS N Relative Risk vs. Return Landscape
If you would invest 11,240 in NOVARTIS N on November 26, 2025 and sell it today you would earn a total of 2,710 from holding NOVARTIS N or generate 24.11% return on investment over 90 days. NOVARTIS N is generating 0.3735% of daily returns and assumes 1.1748% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than NOVARTIS, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
NOVARTIS N Target Price Odds to finish over Current Price
The tendency of NOVARTIS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 139.50 | 90 days | 139.50 | about 1.8 |
Based on a normal probability distribution, the odds of NOVARTIS N to move above the current price in 90 days from now is about 1.8 (This NOVARTIS N probability density function shows the probability of NOVARTIS Stock to fall within a particular range of prices over 90 days) .
NOVARTIS N Price Density |
| Price |
Predictive Modules for NOVARTIS N
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NOVARTIS N. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NOVARTIS N's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NOVARTIS N Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NOVARTIS N is not an exception. The market had few large corrections towards the NOVARTIS N's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NOVARTIS N, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NOVARTIS N within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.27 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 8.76 | |
Ir | Information ratio | 0.19 |
NOVARTIS N Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NOVARTIS N for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NOVARTIS N can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Latest headline from news.google.com: Novartis to Sell 70.68 percent Stake in Indian Unit - Intellectia AI |
NOVARTIS N Fundamentals Growth
NOVARTIS Stock prices reflect investors' perceptions of the future prospects and financial health of NOVARTIS N, and NOVARTIS N fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NOVARTIS Stock performance.
| Current Valuation | 239.79 B | ||||
| Price To Book | 6.09 X | ||||
| Price To Sales | 4.77 X | ||||
| Revenue | 56.67 B | ||||
| Gross Profit | 33.18 B | ||||
| Net Income | 13.98 B | ||||
| Total Debt | 5.52 B | ||||
| Cash Flow From Operations | 19.14 B | ||||
| Total Asset | 110.95 B | ||||
| Retained Earnings | 46.56 B | ||||
About NOVARTIS N Performance
Assessing NOVARTIS N's fundamental ratios provides investors with valuable insights into NOVARTIS N's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the NOVARTIS N is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
NOVARTIS N is entity of Germany. It is traded as Stock on STU exchange.Things to note about NOVARTIS N performance evaluation
Checking the ongoing alerts about NOVARTIS N for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NOVARTIS N help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Latest headline from news.google.com: Novartis to Sell 70.68 percent Stake in Indian Unit - Intellectia AI |
- Analyzing NOVARTIS N's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NOVARTIS N's stock is overvalued or undervalued compared to its peers.
- Examining NOVARTIS N's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NOVARTIS N's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NOVARTIS N's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NOVARTIS N's stock. These opinions can provide insight into NOVARTIS N's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NOVARTIS Stock Analysis
When running NOVARTIS N's price analysis, check to measure NOVARTIS N's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOVARTIS N is operating at the current time. Most of NOVARTIS N's value examination focuses on studying past and present price action to predict the probability of NOVARTIS N's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOVARTIS N's price. Additionally, you may evaluate how the addition of NOVARTIS N to your portfolios can decrease your overall portfolio volatility.